Table 1 Fasting clinical characteristics of the study participants
Normal-weight | Obese | P value | |
|---|---|---|---|
n | 8 | 8 | |
Age (y) | 29 ± 1 | 31 ± 2 | 0.43 |
Body weight (kg) | 72.5 ± 2.1 | 101.1 ± 2.1 | < 0.001 |
BMI (kg/m2) | 22.4 ± 0.5 | 31.8 ± 0.3 | < 0.001 |
Waist circumference (cm) | 83.6 ± 1.7 | 105.6 ± 0.8 | < 0.001 |
HOMA-IR | 0.90 ± 0.14 | 1.75 ± 0.25 | 0.02 |
Total cholesterol (mmol/L) | 4.90 ± 0.23 | 5.04 ± 0.21 | 0.69 |
HDL cholesterol (mmol/L) | 1.53 ± 0.11 | 1.09 ± 0.06 | 0.01 |
LDL cholesterol (mmol/L) | 3.06 ± 0.28 | 3.24 ± 0.18 | 0.64 |
Triacylglycerols (mmol/L) | 0.86 ± 0.06 | 1.46 ± 0.18 | 0.02 |
LPS (EU/mL) | 0.19 ± 0.05 | 0.18 ± 0.04 | 0.73 |
CRP (mg/L) | 1.96 ± 0.01 | 2.98 ± 0.47 | 0.04 |
ASAT (UI/L) | 26.9 ± 2.5 | 30.1 ± 2.7 | 0.44 |
ALAT (UI/L) | 24.9 ± 4.9 | 43.1 ± 6.2 | 0.06 |